-
DMD Gene Therapy Showing ‘Very Encouraging’ Results at 9 Months in Phase 1/2 Study, Sarepta Reports
New data on four Duchenne muscular dystrophy patient in a Phase 1/2 gene therapy trial show an 81.2% increase in dystrophin protein expression in muscles. Click here to learn more.
What are your thoughts on this news?
Sorry, there were no replies found.
Log in to reply.